Top Markets
Coin of the day
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd.

BVXV
Pozycja w akcjach #38550
BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company... BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.
Cena akcji
$0.8
Ostatnia synchronizacja: 2023-10-03
Kapitalizacja rynkowa
$922.40K
Zmiana (1 dzień)
-5.88%
Zmiana (1 rok)
0.00%
Kraj
IL
Handel BiondVax Pharmaceuticals Ltd. (BVXV)

Kategoria

Historia ceny akcji dla BiondVax Pharmaceuticals Ltd. (BVXV)
Najwyższa cena zamknięcia: $0.83 dnia 2023-10-01

Najniższa cena zamknięcia: $44.88 dnia 2015-05-01
Historia cen akcji firmy BiondVax Pharmaceuticals Ltd. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 -87.88%
2022 -64.25%
2021 -42.77%
2020 -52.99%
2019 40.72%
2018 -2.41%
2017 42.21%
2016 -4.29%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE